GRI Bio, Inc. (GRI) Financials

GRI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.5 million 6.4 million
2023-09-30 4.4 million 2.2 million
2023-06-30 5.6 million 1.6 million
2023-03-31 2.1 million 2.1 million

GRI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 123000 ?
2023-09-30 -1.3 million 326000
2023-06-30 -11000 -59000
2023-03-31 -2.1 million 85000

GRI Net Income

No data available :(

GRI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 3.5 million - 28000
2023-06-30 4.8 million - 41000
2023-03-31 1.7 million - -

GRI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 4.9 million
2023-09-30 4.1 million
2023-06-30 2.4 million
2023-03-31 3.0 million

GRI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - - 396000 -
2023-09-30 - 1.2 million 1.3 million -
2023-06-30 8000 880000 5.1 million -
2023-03-31 8000 -124000 2.5 million -

GRI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 5.4 million 2.7 million
2023-09-30 - 1000
2023-06-30 - 2000
2023-03-31 - -

GRI

Price: $0.43

52 week price:
0.43
115.50

Earnings Per Share: -28.25 USD

P/E Ratio: -0.05

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 2375

Market Capitalization: 1.6 million

Average Dividend Frequency: 4

Links: